With Nasal Ease U.S. Launch, Hi-Tech Bids For Allergy Relief Market Share
This article was originally published in The Tan Sheet
Executive SummaryHi-Tech Pharmacal plans to launch its homeopathic allergy reliever Nasal Ease in the U.S. in a bid to capture some of the market share Matrixx Initiatives lost when it withdrew its intranasal Zicam products.
You may also be interested in...
Perrigo debuts Rogaine Foam equivalent; Pfizer patent suit applies heat to J&J/McNeil; Merck KGaA consumer unit beats forecast; Abbott seeks expanded vitamin D3 use; Hi-Tech Pharmacal adds to homeopathics portfolio; more news In Brief.